SK to sign exclusive license agreement for anti-vomiting drug.

Published: 2005-12-23 07:00:00

Updated: 2005-12-23 07:00:00

SK Chemical Life Science Division announced to sign an exclusive distribution agreement with Japanese Nissen Kyroin pharmaceutical company for Sinseron (Indisetron Hcl 8mg), an anti-vomiting and nausea drug.

Sinseron is indicated for the treatment of patients suffering from vomiting and naus...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK